Sickle Cell Disease and Gene Therapy — Patient and Physician Perspectives
NEJM, Youtube video, Septenber 2022
In this short documentary video from the New England Journal of Medicine (NEJM), patients and physicians partner both to highlight the experience of living with sickle cell disease and to discuss the pathophysiology of the disease and new treatment strategies, including gene therapy.
Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma
A Azim et al, J Per Medicine, September 29, 2022
The intra-subject and between-subject variability of each VOC was calculated across the 70 samples and identified 30.35% of VOCs to be erratic: variable between subjects but also variable in the same subject. Exclusion of these erratic VOCs from machine learning approaches revealed no apparent loss of structure to the underlying data or loss of relationship with salient clinical characteristics. Moreover, cluster evaluation by the silhouette coefficient indicates more distinct clustering.
Screening for idiopathic pulmonary fibrosis using comorbidity signatures in electronic health records.
Onishchenko Dmytro et al. Nature medicine 2022 9
Using subtle comorbidity signatures identified from the history of medical encounters of individuals, we developed an algorithm, called the zero-burden comorbidity risk score for IPF (ZCoR-IPF), to predict the future risk of an IPF diagnosis. ZCoR-IPF was trained on a national insurance claims database and validated on three independent databases, comprising a total of 2,983,215 participants, with 54,247 positive cases. The algorithm achieved positive likelihood ratios greater than 30 at a specificity of 0.99 across different cohorts.
A pragmatic clinical trial of cascade testing for familial hypercholesterolemia.
Miller Alexandra A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022 9
We compared new cases detected per index case in familial hypercholesterolemia (FH) families with or without an identifiable monogenic etiology.
We enrolled 52 FH probands with a pathogenic variant (FHg+) in LDLR, APOB, or PCSK9 and 73 probands without such a variant (FHg–). New case detection rate was significantly higher in FH families with a monogenic etiology than in those without such an etiology owing to greater uptake and yield of cascade testing.
Latest News and Publications
Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns.
Martín-Rivada Álvaro et al. Journal of pediatric endocrinology & metabolism : JPEM 2022
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy.
Malgaj Vrecko Marija, et al. Journal of hematology 2022 0 0. (4) 148-153
Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?
Fazzari Melissa J et al. Lupus science & medicine 2022 9(1)
Diverse Approaches to Gene Therapy of Sickle Cell Disease.
White Shanna L et al. Annual review of medicine 2022
Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?
SN van der Craben et al, EJHG, August 26, 2022
Internalizing Symptoms in Adolescents With Sickle Cell Disease.
Heitzer Andrew M et al. Journal of pediatric psychology 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education (SPHERE): a Phase 2 primary stroke prevention trial in sub-Saharan Africa.
Smart Luke R et al. Acta haematologica 2022
Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19.
Xie JunQing, et al. JAMA internal medicine 2022 0 0.
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B.
Bedard Philippe L et al. JCO precision oncology 2022 6e2200165
Mortality and Change in the Prevalence of Deep Vein Thrombosis Associated With SARS-CoV-2 P.1 Variant.
Pereira de Godoy Jose Maria, et al. Cureus 2022 0 0. (7) e26668
Hematological, Biochemical Properties, and Clinical Correlates of Hemoglobin S Variant Disorder: A New Insight Into Sickle Cell Trait.
Khaled Safaa A A et al. Journal of hematology 2022 11(3) 92-108
Sickle Cell Disease: A Review.
Kavanagh Patricia L et al. JAMA 2022 328(1) 57-68
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
McReynolds Lisa J et al. Blood 2022
A Comparison of Logistic Regression Against Machine Learning Algorithms for Gastric Cancer Risk Prediction Within Real-World Clinical Data Streams.
Huang Robert J et al. JCO clinical cancer informatics 2022 6e2200039
Optical absorbance-based rapid test for the detection of sickle cell trait and sickle cell disease at the point-of-care.
Srinivasan Rajesh et al. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 2022 279121394
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.
Aprile Annamaria et al. Pharmaceuticals (Basel, Switzerland) 2022 15(5)
Immunopathogenesis and immunogenetic variants in COVID-19.
Sagulkoo Pakorn, et al. Current pharmaceutical design 2022 0 0.
Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
Lee Yi, et al. BMC infectious diseases 2022 0 0. (1) 462
A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear.
Wang Meifang et al. Frontiers in oncology 2022 12844978
A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile.
Hong Wandong, et al. Frontiers in cellular and infection microbiology 2022 0 0. 819267